SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bierman PJ, Armitage JO. Non-Hodgkin's lymphoma. Curr Opin Hematol. 1996; 3: 266272.
  • 2
    Mansfield PF, Hunt KK. Classification, staging, and management of non-Hodgkin's lymphoma. Cancer Treat Res. 1997; 90: 203211.
  • 3
    Shih LY, Liang DC. Non-Hodgkin's lymphoma in Asia. Hematol Oncol Clin North Am. 1991; 5: 9831001.
  • 4
    Yan Y, Chan WC, Weisenburger DD, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol. 1995; 13: 13361342.
  • 5
    Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol. 1990; 43: 630632.
  • 6
    Naughton MJ, Hess JL, Zutter MM, Barlett NL. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer. 1998; 82: 11541159.
  • 7
    Hanson CA, Kurtin PJ, Katzmann JA, et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood. 1999; 94: 38893896.
  • 8
    Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske S. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol. 1998; 16: 603609.
  • 9
    Brunning RD, McKenna RW. Lesions simulating lymphoma and miscellaneous tumor-like lesions in the bone marrow. In: RosaiJ, editor. Atlas of tumor pathology. vol. 9, 3rd series. Washington, DC: Armed Forces Institute of Pathology, 1994: 409414.
  • 10
    Foucar K. Lymphoid aggregates in bone marrow. In: RogersP, editor. Bone marrow pathology. Chicago: ASCP Press, 1995: 259260.
  • 11
    Fakan F, Skálová, Kuntscherová J. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies. Gen Diagn Pathol. 1996; 141: 359363.
  • 12
    Bluth RF, Casey TT, McCurley TL. Differentiation of reactive from neoplastic small-cell lymphoid aggregates in paraffin-embedded marrow particle preparations using L-26 (CD20) and UCHL-1 (CD45RO) monoclonal antibodies. Am J Clin Pathol. 1993; 99: 150156.
  • 13
    Deverell MH, Best E, Salisbury JR. Lymphoid infiltrates in B cell non Hodgkin's lymphoma: comparing nuclear characteristics between lymph node and bone marrow; and evaluating diagnostic features of bone marrow infiltrates in paraffin embedded tissues. Anal Cell Pathol. 1997; 14: 17.
  • 14
    Salisbury JR, Deverell MH, Seaton JM, Cookson MJ. Three-dimensional reconstruction of non-Hodgkin's lymphoma in bone marrow trephines. J Pathol. 1997; 181: 451454.
  • 15
    Cossman J, Zehnbauer B, Garrett CT, et al. Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. Am J Clin Pathol. 1991; 95: 347354.
  • 16
    Ellison DJ, Hu E, Zovich D, Pinter-Brown L, Pattengale PK. Immunogenetic analysis of bone marrow aspirates in patients with non-Hodgkin lymphoma. Am J Hematol. 1990; 33: 160166.
  • 17
    Chen PM, Fan S, Lin SH, et al. Study of bone marrow cells in non-Hodgkin's lymphoma by DNA analysis. Leuk Res. 1991; 15: 10971106.
  • 18
    Lehman CM, Sarago C, Nasim S, Comerford J, Karcher DS, Garrett CT. Comparison of PCR versus Southern hybridization for the routine detection of immunoglobulin heavy chain gene rearrangements. Am J Clin Pathol. 1995; 103: 171176.
  • 19
    Sioutos N, Bagg A, Michaud GY, et al. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol. 1995; 4: 813.
  • 20
    Weiss LM, Spagnolo DV. Assessment of clonality in lymphoid proliferations. Am J Pathol. 1993; 142: 16791682.
  • 21
    Rezuke WN, Abernathy EC, Tsongalis GJ. Molecular diagnosis of B- and T-cell lymphoma: fundamental principles and clinical applications. Clin Chem. 1997; 43: 18141823.
  • 22
    Coad JE, Olson DJ, Christensen DR, et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol. 1997; 21: 10471056.
  • 23
    Crotty PL, Smith BR, Tallini G. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma. Diagn Mol Pathol. 1998; 7: 9095.
  • 24
    Kim YS, Kang CS, Han K, et al. Detection of minimal lesion and identification of clonality in malignant lymphoma. Korean J Pathol. 1998; 32: 298308.
  • 25
    Kröber SM, Horny HP, Greschniok A, Kaiserling E. Reactive and neoplastic lymphocytes in human bone marrow: morphological, immunohistological, and molecular biological investigations on biopsy specimens. J Clin Pathol. 1999; 52: 521526.
  • 26
    Pittaluga S, Tierens A, Dodoo YL, Delabie J, Wolf-Peeters CD. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am J Clin Pathol. 1999; 111: 179184.
  • 27
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84: 13611392.
  • 28
    A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993; 329: 987994.
  • 29
    Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
  • 30
    Seo EJ, Chi HS. Bone marrow involvement by non-Hodgkin's lymphoma: incidence, histopathology and diagnostic efficacies. Korean J Clin Pathol. 1994; 14: 2029.
  • 31
    Torlakovic E, Cherwitz DL, Jessurun J, Scholes J, McGlennen R. B-cell gene rearrangement in benign and malignant lymphoid proliferations of mucosa-associated lymphoid tissue and lymph nodes. Hum Pathol. 1997; 28: 166173.
  • 32
    Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood. 1991; 78: 192196.
  • 33
    Lozano MD, Tierens A, Greiner TC, Wickert RC, Weisenburger DD, Chan WC. Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer. 1996; 77: 13491355.
  • 34
    Tewari D. Clonal analysis of the human B-cell repertoire using a heteromobility assay. Clin Diagn Lab Immunol. 2000; 7: 507509.
  • 35
    Cabras AD, Candidus S, Fend F, et al. Biclonality of gastric lymphomas. Lab Invest. 2001; 81: 961967.
  • 36
    Potter MN, Cross NC, van Dongen JJ,et al. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review. Leukemia. 1993; 7: 13021314.
  • 37
    Medeiros LJ, Weiss LM. The utility of the polymerase chain reaction as a screening method for the detection of antigen receptor gene rearrangements. Hum Pathol. 1994; 25: 12611263.
  • 38
    Sharp JG, Joshi SS, Armitage JO, et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood. 1992; 79: 10741080.
  • 39
    Gribben JG, Neuberg D, Freedman AS, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood. 1993; 81: 34493457.
  • 40
    Chen PM, Fan S, Lin SH, et al. Study of bone marrow cells in non-Hodgkin's lymphoma by DNA analysis. Leuk Res. 1991; 15: 10971106.